+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

PD-1 and PD-L1 Inhibitors - Competitive Landscape, 2024 - Product Thumbnail Image

PD-1 and PD-L1 Inhibitors - Competitive Landscape, 2024

  • Clinical Trials
  • December 2024
  • 280 Pages
  • Global
From
Lupus Nephritis - Pipeline Insight, 2024 - Product Thumbnail Image

Lupus Nephritis - Pipeline Insight, 2024

  • Clinical Trials
  • November 2024
  • 80 Pages
  • Global
From
From
Gout - Pipeline Insight, 2024 - Product Thumbnail Image

Gout - Pipeline Insight, 2024

  • Clinical Trials
  • November 2024
  • 80 Pages
  • Global
From
Myositis - Pipeline Insight, 2024 - Product Thumbnail Image

Myositis - Pipeline Insight, 2024

  • Drug Pipelines
  • November 2024
  • 80 Pages
  • Global
From
Graves' Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Graves' Disease - Pipeline Insight, 2024

  • Drug Pipelines
  • November 2024
  • 60 Pages
  • Global
From
From
Post-Transplant Lymphoproliferative Disorder - Pipeline Insight, 2024 - Product Thumbnail Image

Post-Transplant Lymphoproliferative Disorder - Pipeline Insight, 2024

  • Clinical Trials
  • August 2024
  • 60 Pages
  • Global
From
Scleroderma - Pipeline Insight, 2024 - Product Thumbnail Image

Scleroderma - Pipeline Insight, 2024

  • Clinical Trials
  • August 2024
  • 240 Pages
  • Global
From
Chronic rhinosinusitis with nasal polyps - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic rhinosinusitis with nasal polyps - Pipeline Insight, 2024

  • Clinical Trials
  • August 2024
  • 60 Pages
  • Global
From
Autoimmune Hepatitis - Pipeline Insight, 2024 - Product Thumbnail Image

Autoimmune Hepatitis - Pipeline Insight, 2024

  • Clinical Trials
  • August 2024
  • 60 Pages
  • Global
From
Crohn's Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Crohn's Disease - Pipeline Insight, 2024

  • Clinical Trials
  • August 2024
  • 240 Pages
  • Global
From
From
Toll-Like Receptor 8 Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Toll-Like Receptor 8 Agonist - Pipeline Insight, 2024

  • Drug Pipelines
  • July 2024
  • 60 Pages
  • Global
From
Urticaria - Pipeline Insight, 2024 - Product Thumbnail Image

Urticaria - Pipeline Insight, 2024

  • Drug Pipelines
  • July 2024
  • 80 Pages
  • Global
From
Vitiligo - Pipeline Insight, 2024 - Product Thumbnail Image

Vitiligo - Pipeline Insight, 2024

  • Clinical Trials
  • July 2024
  • 80 Pages
  • Global
From
Ankylosing Spondylitis - Pipeline Insight, 2024 - Product Thumbnail Image

Ankylosing Spondylitis - Pipeline Insight, 2024

  • Clinical Trials
  • July 2024
  • 80 Pages
  • Global
From
Alopecia Areata - Pipeline Insight, 2024 - Product Thumbnail Image

Alopecia Areata - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 80 Pages
  • Global
From
From
From
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more